Tumor Biology for the Clinician: Melanoma Peptide Vaccines

Cancer Control - United States
doi 10.1177/107327489500200513
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Relating TCR-peptide-MHC Affinity to Immunogenicity for the Design of Tumor Vaccines

Journal of Clinical Investigation
Medicine
2006English

Melanoma Vaccines.

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1998English

Vaccine Trials for the Clinician: Prospects for Tumor Antigens

Oncologist
Cancer ResearchMedicineOncology
1997English

Synthetic Peptide Vaccines

Journal of Medical Microbiology
MedicineMicrobiology
1993English

Synthetic Biology for Bioengineering Virus-Like Particle Vaccines

Biotechnology and Bioengineering
Applied MicrobiologyBiotechnologyBioengineering
2018English

Targeting Angiogenesis With Peptide Vaccines

Frontiers in Immunology
AllergyImmunology
2019English

Disordered Epitopes as Peptide Vaccines

Peptide Science
BiochemistryOrganic ChemistryBiomaterialsBiophysics
2018English

Allogeneic Tumor Cell Vaccines

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Peptide-Based Immunotherapeutics and Vaccines 2017

Journal of Immunology Research
MedicineAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy